Varicose Veins Treatment Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Varicose veins are enlarged, twisted superficial veins that commonly appear in the legs, affecting roughly 25-30% of adults worldwide, with higher prevalence among women and older populations. The treatment landscape spans conservative approaches such as compression garments and elevation, alongside interventional options including endovenous laser and radiofrequency ablation, foam sclerotherapy, and surgical stripping. Valued at approximately $4.8 billion in 2025, the global market is expanding as awareness of both medical and cosmetic venous treatments grows.

• •Affects an estimated 25-30% of adults globally, with increased prevalence in females and individuals over 50
• •Treatment spectrum ranges from conservative compression therapy to minimally invasive endovenous ablation procedures

The aging global population is the dominant growth engine, as venous valve function deteriorates with age and the number of adults over 50 continues to rise across developed and developing economies. Concurrently, increasing obesity rates, sedentary occupations, and prolonged standing contribute to greater venous pressure and higher incidence of chronic venous disorders. Minimally invasive, office-based procedures that reduce recovery time and hospital costs are accelerating adoption, while insurance coverage expansion in several markets is improving patient access.

• •Rising global population of older adults increases the pool of patients with venous insufficiency and varicose vein disease
• •Growing preference for minimally invasive, outpatient procedures over traditional surgical stripping is broadening market reach

North America holds the largest market share, supported by high healthcare spending, widespread insurance reimbursement for venous interventions, and strong clinical adoption of advanced ablation technologies. Europe represents a mature but steady market, particularly in Western Europe where aging populations and well-established vascular surgery infrastructure drive consistent demand. The Asia-Pacific region is emerging as the fastest-growing segment, fueled by rising healthcare access, medical tourism in countries such as India and Thailand, and increasing demand for both therapeutic and cosmetic venous treatments.

• •North America leads in market share, backed by high procedure volumes and comprehensive insurance coverage
• •Asia-Pacific is the fastest-growing regional market, driven by expanding healthcare access and medical tourism

What are the recent trends and outlook?

A defining trend is the migration of treatments from hospital operating rooms to office-based ambulatory settings, where ultrasound-guided procedures offer lower costs and faster patient recovery. Combination therapies, pairing endovenous ablation with foam sclerotherapy to address both the main trunk and tributary veins in a single session, are gaining clinical acceptance as integrated protocols. Looking ahead, expanding clinical evidence for treating chronic venous insufficiency and venous leg ulcers, combined with continued device innovation, is expected to sustain the market's mid-single-digit annual growth trajectory.

• •Office-based, ultrasound-guided ambulatory procedures are increasingly replacing traditional surgical approaches
• •Combination therapy protocols that integrate ablation with sclerotherapy are gaining broader clinical adoption